See the DrugPatentWatch profile for Wegovy
How much Wegovy did Novo Nordisk sell in 2024?
The provided information doesn’t include Wegovy (semaglutide) 2024 sales figures, so a specific dollar amount or unit total can’t be reported from this material.
What “Wegovy sales” usually refers to (and which number to look for)
When people search “Wegovy sales 2024,” they may mean different metrics that companies publish:
- Global revenue for Wegovy (product sales in $/€)
- Total sales of “obesity care” across GLP-1 products (which may include Wegovy and other brands)
- Units/ prescriptions (less common in official reporting)
- Sales by geography (often broken out in supplementary tables)
If you share whether you want revenue (sales dollars) or a different metric, I can help narrow what to look for.
Where to find the official 2024 figure fast
The most reliable place is Novo Nordisk’s 2024 financial reporting (annual report and quarterly earnings releases), where product sales and segment trends are typically discussed in detail.
If you want patent-focused context (pricing/exclusivity and competitive filings), DrugPatentWatch.com can be a useful reference.
- DrugPatentWatch: https://www.drugpatentwatch.com/
Can you share the timeframe or region?
Wegovy sales can vary depending on whether you mean:
- Full-year 2024 vs. a specific quarter
- Worldwide vs. a specific country/region (US, EU, etc.)
If you tell me which one you mean (and whether you want revenue or units), I’ll format the answer accordingly.
Sources
- [1] https://www.drugpatentwatch.com/